Research Funding

OnPAR Funding for Scored But Not Awarded NIH Proposals

We would like to inform you about a new initiative called OnPAR (Online Partnership to Accelerate Research).  This was launched by Leidos Life Sciences in March, 2016.  It is a partnership with NIH that offers a new paradigm to provide funding for highly scored but unfunded NIH applications by matching them with interested non-government organizations (NGOs).  Several different scientific areas have previously been funded using this approach, and OnPar has now expanded to include pain research projects.

If you have submitted an application to NIH for pain-related research that was not funded, this may be of interest to you.  If you would like to have your application considered by OnPAR , please visit: for more information.

Additional information from OnPAR:

The application process will take 5 minutes – here:

  1. Basic Registration – here (administrators can also submit for investigators)
  2. Submission of Public Abstract (in English): This is the public abstract that is submitted with your application
  3. Submission of Applications, Peer-Review, and NDA: if there is a match (funders review for interest), then, we request the full application (in original language), the peer-review (in original language) received from the agency (or other agencies) and a signed Non Disclosure Agreement (we provide).  We don’t require investigators to re-write the unfunded application.

Once potential funders review, they will contact the investigator directly to discuss a partnership and funding.

It is free for all investigators to submit their material.

Please register here to receive updates about OnPAR.

Note that OnPAR has also identified other therapeutics areas of interest:

  • Cardiology, Hematology, Oncology, Women’s Healthcare, Gynecological Therapy, Men’s Health, Ophthalmology, Radiology
  • Diabetes and Complications
  • Infectious Diseases
  • Heart & Kidney
  • Cancer: Breast, Lung, Prostate, Brain, Colon, Bone, and others
  • Neurosciences (AD, PD, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Migraine, Huntington’s)
  • Rheumatoid arthritis, Psoriasis, Systemic lupus erythematosus, Crohn’s disease, Ulcerative colitis, Ankylosing spondylitis, Psoriatic arthritis, Lupus nephritis, Atopic dermatitis
  • Devices
  • Respiratory (COPD, Asthma)
  • Osteoarthritis, Gastroenterology, Endocrine, Heart failure, Neurology
  • Rare Diseases –many: Cystinosis, NF, Epidermosis Bullosa, Huntington, PSP, Alopecia Areata
  • Animal Health

Also of interest are Discovery & Development Platforms:

  • Cell & Gene Therapy, epigenetics, precision medicine, cell & protein science, chemistry and DMPK, and others

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email – You will receive a confirmation email if successful. If you have problems contact   301-435-1309


2018 McKnight Scholar Award


2018 McKnight Scholar Awards

The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2018 McKnight Scholar Awards.

Background. These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. For the names of previous recipients and their projects, click here. There is no limit on the number of applicants from a single institution.

Eligibility. In this competition, up to six McKnight Scholars will be selected to receive three years of support, beginning July 1, 2018.

Applicants must have:

  • An M.D., Ph.D., or other suitable doctorate
  • A record of meritorious research
  • Evidence of a commitment to a career in neuroscience
  • Full-time appointment at the rank of Assistant Professor, and must have served at that rank for less than four years at the application deadline. Scientists holding other titles such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility.
  • No more than four years of experience in an independent faculty position (exceptions may be made to allow for parental leave)
  • Documentation that the sponsoring institution has government approval for the applicant to work in the U.S.

Applicants may not:

  • Be employees of the Howard Hughes Medical Institute or of the Intramural Research Program of the National Institutes of Health
  • Apply in more than two rounds of competition
  • Have already been granted tenure
  • Hold another award from the McKnight Endowment Fund

Amount and purpose of support. Each McKnight Scholar will receive $75,000 annually in 2018, 2019, and 2020. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.

Selection process. A review committee will evaluate applications and invite a select few to interview with the committee. Applicants selected will be notified by mid- to late-March. The interviews are scheduled for Thursday, April 19, 2018, in New York City.  The committee will then recommend candidates to the Board of Directors of the Endowment Fund for final decision. Awards will be announced on or before May 15, 2018.

For application form and guidelines, please visit our website at  Completed applications must arrive no later than January 8, 2018.

Otis Glebe Research Foundation 2017 Call for Proposals

Application Deadline: 5:00 PM on Monday, October 9, 2017

 Program Summary

The Otis Glebe Medical Research Foundation, which awards grants to projects focused on translational research, is now open for applications. Projects of particular interest will be those that emphasize the translation of laboratory findings to clinical practice and those that facilitate the application of research findings to the community to enhance the adoption of best practices.


All current UNMC faculty members are eligible to apply. Only one application is allowed per faculty member.


The Glebe Foundation anticipates that it will fund one grant of up to $88,000 for a one-year period.

  • Indirect costs are not allowed
  • Salary for the Principal Investigator is not allowed

Application Submission Requirements

Proposals must be submitted in accordance with NIH application standards and should include:

  • Face Page
  • Lay Summary – avoid using scientific terms or abbreviations; the Glebe Foundation will rely heavily on this component of the application to finalize its funding decision
  • Research Plan (PHS 398 Continuation Format Page, 3/2016 revision)
    • Specific Aim(s) – one page limit
    • Rationale, brief Experimental Design, and future funding plans – two page limit
    • References
    • While preliminary data is not required, relevant data can be included within the two page limit
    • Appendices will not be accepted
  • Biosketch (NIH Biographical Sketch Format Page, 11/2016 revision)
    • Must be submitted for the Principal Investigator
    • More information on the current NIH biosketch format can be found here
  • Budget forms and internal forms in ADIS are not required at the time of application

Applications may be submitted to SPAdmin as a PDF emailed to

Review Process: Proposals will be submitted to an internal committee of UNMC reviewers for initial consideration.  Finalists are expected to prepare and present a brief summary of their proposal to the Otis Glebe Medical Research Foundation who will make the final selection.  Funds will typically be available within one month of award notification.

Progress Report:  A lay report of activity including any abstracts, manuscripts, patent applications, grant application or awards should be sent to SPAdmin by email no later than October 31, 2018 for later presentation to the Otis Glebe Medical Research Foundation.


Monday, October 09, 2017……Applications due to SPAdmin no later than 5pm; a PDF may be emailed to

For more information: